Finance

Lists
MD:NYSE
Pediatrix Medical Group Inc
US$ २६.६४
+१.५२%
(+०.४०) 1D
US$ २६.६४
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MD...
Open
US$ २६.३५
High
US$ २६.८६
Low
US$ २६.३३
Mkt. cap
२.१६ अरब
Avg. vol.
७.४४ लाख
Volume
५.१८ लाख
P/E ratio
१२.८०
52-wk high
US$ २७.९४
52-wk low
US$ १५.७०
EPS
US$ २.०८
Beta
०.६१
Shares outstanding
८.१३ करोड
No. of employees
४ हजार
Open
US$ २६.३५
High
US$ २६.८६
Low
US$ २६.३३
Mkt. cap
२.१६ अरब
Avg. vol.
७.४४ लाख
Volume
५.१८ लाख
P/E ratio
१२.८०
52-wk high
US$ २७.९४
52-wk low
US$ १५.७०
EPS
US$ २.०८
Beta
०.६१
Shares outstanding
८.१३ करोड
No. of employees
४ हजार
News stories
From web sources and news partners
About Pediatrix Medical Group Inc
CEOJames D. Swift
Employees४.२८ हजार
Founded२००७
Headquarters-
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to MD in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MD in the last 3 months.
Highest
Current US$ २६.६४
US$ २८.०० (+५.११%)
Average
US$ २७.४० (+२.८५%)
Lowest
US$ २५.०० (-६.१६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jack Slevin
Jefferies
Hold
Downgraded
US$ २८.००
+५.१%
08/19/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
US$ २८.००
+५.१%
08/11/2026
A.J. Rice
UBS
Hold
Maintained
US$ २८.००
+५.१%
08/06/2026
David S Macdonald
Truist Financial
Hold
Maintained
US$ २८.००
+५.१%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
US$ २५.००
-६.२%
08/05/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/04/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
-
-
02/20/2026
Last report
२०२६ अगस्ट ४
Fiscal period
Q2 2026
US$ ०.६३ / US$ ०.५९
+६.६०%beat
Revenue / Est. (USD)
४८.७८ करोड / ४७.८० करोड
+२.०५%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४९.२९ करोड
४९.३८ करोड
४७.६२ करोड
४८.७८ करोड
Cost of goods sold
३५.२५ करोड
३६.७८ करोड
३६.३२ करोड
३५.५३ करोड
Cost of revenue
३५.२५ करोड
३६.७८ करोड
३६.३२ करोड
३५.५३ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.०८ करोड
६.५७ करोड
६.०३ करोड
६.१३ करोड
Operating expense
६.६३ करोड
७.१३ करोड
६.६४ करोड
६.७१ करोड
Total operating expenses
४१.८९ करोड
४३.९१ करोड
४२.९६ करोड
४२.२४ करोड
Operating income
७.४० करोड
५.४७ करोड
४.६६ करोड
६.५४ करोड
Other non operating income
-
-
-
-
EBT including unusual items
८.७८ करोड
४.५६ करोड
३.८८ करोड
५.४० करोड
EBT excluding unusual items
७.२८ करोड
५.१५ करोड
४.३८ करोड
६.२५ करोड
Income tax expense
१.६१ करोड
१.१९ करोड
९२.७२ लाख
१.४२ करोड
Effective tax rate
१८.३१%
२६.१३%
२३.८७%
२६.२२%
Other operating expenses
-
-
-
-
Net income
७.१७ करोड
३.३७ करोड
२.९६ करोड
३.९८ करोड
Net profit margin
१४.५५%
६.८२%
६.२१%
८.१७%
Earnings per share
०.६७
०.५०
०.४४
०.६३
Interest and investment income
५८.८३ लाख
४६.९८ लाख
४७.६० लाख
४५.४८ लाख
Interest expense
-८९.४१ लाख
-८७.४० लाख
-८२.६५ लाख
-८१.७२ लाख
Net interest expenses
-३०.५८ लाख
-४०.४२ लाख
-३५.०५ लाख
-३६.२४ लाख
Depreciation and amortization charges
५५.५१ लाख
५६.३१ लाख
६१.१९ लाख
५७.८२ लाख
EBITDA
७.९६ करोड
६.०३ करोड
५.२७ करोड
७.१२ करोड
Gain or loss from assets sale
-२.०९ करोड
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू